Dynamic flaps in HIV-1 protease adopt unique ordering at different stages in the catalytic cycle
Suresh Karthik
Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India
Search for more papers by this authorCorresponding Author
Sanjib Senapati
Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India
Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India===Search for more papers by this authorSuresh Karthik
Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India
Search for more papers by this authorCorresponding Author
Sanjib Senapati
Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India
Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600036, India===Search for more papers by this authorAbstract
The flexibility of HIV-1 protease flaps is known to be essential for the enzymatic activity. Here we attempt to capture a multitude of conformations of the free and substrate-bound HIV-1 protease that differ drastically in their flap arrangements. The substrate binding process suggests the opening of active site gate in conjunction with a reversal of flap tip ordering, from the native semiopen state. The reversed-flap, open-gated enzyme readily transforms to a closed conformation after proper placement of the substrate into the binding cleft. After substrate processing, the closed state protease which possessed opposite flap ordering relative to the semiopen state, encounters another flap reversal via a second open conformation that facilitates the evolution of native semiopen state of correct flap ordering. The complicated transitional pathway, comprising of many high and low energy states, is explored by combining standard and activated molecular dynamics (MD) simulation techniques. The study not only complements the existing findings from X-ray, NMR, EPR, and MD studies but also provides a wealth of detailed information that could help the structure-based drug design process. Proteins 2011; © 2011 Wiley-Liss, Inc.
Supporting Information
Additional Supporting Information may be found in the online version of this article.
Filename | Description |
---|---|
PROT_23008_sm_suppinformation.pdf1 MB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1 Kohl NE,Emini EA,Schleif WA,Davis LJ,Heimbach JC,Dixon RAF,Scolnick EM,Sigal IS. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 1998; 85: 4686–4690.
- 2 Wlodawer A,Miller M,Jaskolski M,Sathyanarayana BK,Baldwin E,Weber IT,Selk LM,Clawson L,Schneider J,Kent SB. Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science 1989; 245: 616–621.
- 3 Spinelli S,Liu QZ,Alzari PM,Hirel PH,Poljak RJ. The three dimensional structure of aspartyl protease from HIV-1 isolate BRU. Biochimie 1991; 73: 1391–1396.
- 4 Kim EE,Baker CT,Dwyer MD,Murcko MA,Rao BG,Tung RD,Navia MA. Crystal structure of HIV-1 Protease in complex with vx-478, a potent and orally bioavailable inhibitor of the enzyme. J Am Chem Soc 1995; 117: 1181–1182.
- 5 Mahalingam B,Wang YF,Boross PI,Tozser J,Louis JM,Harrison RW,Weber IT. Crystal structures of HIV protease V82A and L90M mutants reveal changes in the indinavir-binding site. Eur J Biochem 2004; 271: 1516–1524.
- 6 Clemente JC,Coman RM,Thiaville MM,Janka LK,Jeung JA,Nukoolkarn S,Govindasamy L,Mckenna MA,Mckenna R,Leelamanit W,Goodenow MM,Dunn BM. Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: Structural determinants for maintaining sensitivity and developing resistance to Atazanavir. Biochemistry 2006; 45: 5468–5577.
- 7 Altman MD,Nalivaika EA,Jeyabalan MP,Schiffer CA,Tidor B. Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease. Proteins: Struct Funct Bioinf 2008; 70: 678–694.
- 8 Hornak V,Simmerling C. Targeting structural flexibility in HIV-1 Protease inhibitor binding. Drug Discov Today 2007; 12: 132–138.
- 9 Hornak V,Okur A,Rizzo RC,Simmerling C. HIV-1 Protease flaps spontaneously close to the correct structure in simulations following manual placements of an inhibitor in the active site. J Am Chem Soc 2006; 128: 2812–2813.
- 10 Collins JR,Burt SK,Erickson JW. Flap opening in HIV-1 protease simulated by activated molecular dynamics. Nat Struct Biol 1995; 2: 334–338.
- 11 Hornak V,Okur A,Rizzo RC,Simmerling C. HIV-1 Protease flaps spontaneously open and reclose in molecular dynamics simulations. Proc Natl Acad Sci USA 2006; 103: 915–920.
- 12 Ishima R,Freedberg DI,Wang YX,Louis JM,Torchia DA. Flap opening and dimer-interface flexibility in the free and inhibitor bound HIV Protease, and their implications for function. Structure 1999; 7: 1047–1055.
- 13 Kato K,Yamazaki T,Louis JM,Torchia DA,Ishima R. A solution NMR study of the binding kinetics and the internal dynamics of an HIV-1 Protease-substrate complex. Protein Sci 2003; 12: 1376–1385.
- 14 Toth G,Borics A. Closing of the flaps of HIV-1 protease induced by substrate binding: a model of flap closing mechanism in retroviral aspartic proteases. Biochemistry 2006; 45: 6606–6614.
- 15 Nicholson L,Yamazaki T,Torchia DA,Grzeseik S,Bax A,Stahl SJ,Kaufman JD,Wingfield PT,Lam PY,Jadhav PK. Flexibility and function in HIV-1 Protease. Nat Struct Biol 1995; 2: 274–280.
- 16 Freedberg DI,Ishima R,Jacob J,Wang XY,Kustanovich I,Louis JM,Torchia DA. Rapid structural fluctuations of HIV-1 protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamic calculations. Protein Sci 2002; 11: 221–232.
- 17 Scott WRP,Schiffer CA. Curling of flaps tips in HIV-1 Protease as a mechanism for substrate entry and tolerance of drug resistance. Structure 2000; 8: 1259–1265.
- 18 Toth G,Borics A. Flap opening mechanism of HIV-1 protease. J Mol Graph Mod 2006; 24: 465–474.
- 19 Chang C,Shen T,Trylska J,Tozzini V,McCammon JA. Gated binding of ligands to HIV-1 protease: Brownian Dynamics simulations in a coarse-grained model. Biophys J 2006; 90: 3880–3885.
- 20 Trylska J,Tozzini V,Chang CA,McCammon JA. HIV-1 protease substrate binding and product release pathways explored with coarse grained molecular dynamics. Biophys J 2007; 92: 4179–4187.
- 21 Singh G,Senapati S. Molecular dynamics simulations of Ligand-induced flap closing in HIV-1 protease approach X-ray resolution: establishing the role of bound water in the flap closing mechanism. Biochemistry 2008; 47: 10657–10664.
- 22 Chang CA,Trylska J,Tozzini V,McCammon JA. Binding pathways of ligands to HIV-1 protease: Coarse-grained and Atomistic simulations. Chem Biol Drug Des 2007; 69: 5–13.
- 23 Pietrucci F,Marinelli F,Carloni P,Laio A. Substrate binding mechanism of HIV-1 protease from explicit solvent atomic simulations. J Am Chem Soc 2009; 131: 11811–11818.
- 24 Sadiq SK,Fabritiis GD. Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing. Proteins: Struct Funct Bioinf 2010; 78: 2873–2885.
- 25 Darve E,Pohorille A. Calculating free energies using average force. J Chem Phys 2001; 115: 9169–9183.
- 26 Henin J,Chitpot C. Overcoming free energy barriers using unconstrained molecular dynamics simulations. J Chem Phys 2004; 121: 2904–2914.
- 27 Heaslet H,Rosenfield R,Giffin M,Lin YC,Tam K,Torbett BE,Elder JH,McRee DE,Stout CD. Conformational flexibility in the flap domains of ligand-free HIV-1 Protease. Acta Cryst D 2007; 3: 866–875.
- 28 Case DA,Darden TA,Cheatham III, TE,Simmerling CL,Wang J,Duke RE,Luo R,Merz KM,Pearlman DA,Crowley M,Walker RC,Zhang W,Wang B,Hayik S,Roitberg A,Seabra G,Wong KF,Paesani F,Wu X,Brozell S,Tsui, V,Gohlke H,Yang L,Tan C,Mongan J,Hornak V,Cui G,Beroza P,Mathews DH,Schafmeister C,Ross WS,Kollman PA, Amber 9.0. University of California, San Francisco, CA, 2006.
- 29 Hornak V,Abel R,Okur A,Strockbine B,Roitberg A,Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Struct Funct Bioinf 2006; 65: 712–725.
- 30 Philips JC,Braun R,Wang W,Gumbart J,Tajkhorshid E,Villa E,Chitpot C,Skeel RD,Kale L,Schulten K. Scalable molecular dynamics with NAMD. J Comp Chem 2005; 26: 1781–1802.
- 31 Gorfe AA,Babakhani A,McCammon JA. Free energy profile of H-ras membrane anchor upon membrane insertion. Angew Chem Int Ed Engl 2007; 46: 8234–8237.
- 32 Xu J,Crowley MF,Smith JC. Building a foundation for structure-based cellulosome design for cellulosic ethanol: insight into Cohesin-Dockerin complexation from computer simulation. Protein Sci 2009; 18: 949–959.
- 33 Galiano L,Bonora M,Fanucci GE. Interflap distances in HIV-1 protease determined by pulsed EPR measurements. J Am Chem Soc 2007; 129: 11004–11005.
- 34 Torbeev VY,Raghuraman H,Mandal K,Senapati S,Perozo E,Kent SBH. Dynamics of “flap” structures in three HIV-1 protease/inhibitor complexes probed by total chemical synthesis and pulse-EPR spectroscopy. J Am Chem Soc 2008; 131: 884–885.
- 35 Layten M,Hornak V,Simmerling C. The open structure of a multi-drug-resistant HIV-1 protease is stabilized by crystal packing contacts. J Am Chem Soc 2006; 128: 13360–13361.
- 36 Tozzini V,Trylska J,Chang CA,McCammon JA. Flap opening dynamics in HIV-1 Protease explored with a coarse-grained model. J Struct Biol 2007; 157: 606–615.
- 37 Wang YX,Freedberg DI,Yamazaki T,Wingfield PT,Stahl SJ,Kaufman JD,Kiso Y,Torchia DA. Mapping hydration water molecules in HIV-1 Protease/DMP323 complex in solution by NMR spectroscopy. Biochemistry 1996; 35: 9945–9950.
- 38
Piana S,Carloni P.
Conformational flexibity of the catalytic Asp dyad in HIV-1 Protease: an ab initio study on the free enzyme.
Proteins: Struct Funct Genet
2000;
39:
26–36.
10.1002/(SICI)1097-0134(20000401)39:1<26::AID-PROT3>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- 39 Northrop DB. Follow the protons: a low barrier hydrogen bond unifies the mechanisms of aspartic proteases. Acc Chem Res 2001; 34: 790–797.
- 40 Trylska J,Grochowski P,McCammon JA. The role of hydrogen bonding in the enzymatic reaction catalyzed by HIV-1 protease. Protein Sci 2004; 13: 513–528.